Literature DB >> 16220143

Students investigating the antiproliferative effects of synthesized drugs on mouse mammary tumor cells.

Rasha Hammamieh1, Margery Anderson, Katharine Carr, Christine N Tran, Debra L Yourick, Marti Jett.   

Abstract

The potential for personalized cancer management has long intrigued experienced researchers as well as the naïve student intern. Personalized cancer treatments based on a tumor's genetic profile are now feasible and can reveal both the cells' susceptibility and resistance to chemotherapeutic agents. In a weeklong laboratory investigation that mirrors current cancer research, undergraduate and advanced high school students determine the efficacy of common pharmacological agents through in vitro testing. Using mouse mammary tumor cell cultures treated with "unknown" drugs historically recommended for breast cancer treatment, students are introduced to common molecular biology techniques from in vitro cell culture to fluorescence microscopy. Student understanding is assessed through laboratory reports and the successful identification of the unknown drug. The sequence of doing the experiment, applying logic, and constructing a hypothesis gives the students time to discover the rationale behind the cellular drug resistance assay. The breast cancer experiment has been field tested during the past 5 yr with more than 200 precollege/undergraduate interns through the Gains in the Education of Mathematics and Science program hosted by the Walter Reed Army Institute of Research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16220143      PMCID: PMC1200777          DOI: 10.1187/cbe.04-10-0053

Source DB:  PubMed          Journal:  Cell Biol Educ        ISSN: 1536-7509


  14 in total

Review 1.  Mutations of BRCA genes in hereditary breast and ovarian cancer.

Authors:  P Radice
Journal:  J Exp Clin Cancer Res       Date:  2002-09

Review 2.  Proliferation, cell cycle and apoptosis in cancer.

Authors:  G I Evan; K H Vousden
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

3.  Pretesting tumors.

Authors:  E Strauss
Journal:  Sci Am       Date:  1999-02       Impact factor: 2.142

4.  Lipoxygenase inhibitors attenuate growth of human pancreatic cancer xenografts and induce apoptosis through the mitochondrial pathway.

Authors:  Wei-Gang Tong; Xian-Zhong Ding; Richard C Witt; Thomas E Adrian
Journal:  Mol Cancer Ther       Date:  2002-09       Impact factor: 6.261

Review 5.  BRCA proteins and DNA damage checkpoints.

Authors:  Zhenkun Lou; Junjie Chen
Journal:  Front Biosci       Date:  2003-05-01

6.  Synthesis and anticancer activity of nordihydroguaiaretic acid (NDGA) and analogues.

Authors:  R W McDonald; W Bunjobpon; T Liu; S Fessler; O E Pardo; I K Freer; M Glaser; M J Seckl; D J Robins
Journal:  Anticancer Drug Des       Date:  2001-12

Review 7.  Current strategies for anticancer chemoprevention and chemoprotection.

Authors:  Krzysztof L Krzystyniak
Journal:  Acta Pol Pharm       Date:  2002 Nov-Dec       Impact factor: 0.330

8.  Nordihydroguaiaretic acid: hepatotoxicity and detoxification in the mouse.

Authors:  Joshua D Lambert; Dedun Zhao; Ross O Meyers; Robert K Kuester; Barbara N Timmermann; Robert T Dorr
Journal:  Toxicon       Date:  2002-12       Impact factor: 3.033

Review 9.  Nutritional and botanical modulation of the inflammatory cascade--eicosanoids, cyclooxygenases, and lipoxygenases--as an adjunct in cancer therapy.

Authors:  Jeanne M Wallace
Journal:  Integr Cancer Ther       Date:  2002-03       Impact factor: 3.279

10.  COX inhibitors modulate bFGF-induced cell survival in MCF-7 breast cancer cells.

Authors:  Swee H Teh; Arnold K Hill; Deidre A Foley; Edna W McDermott; Niall J O'Higgins; Leonie S Young
Journal:  J Cell Biochem       Date:  2004-03-01       Impact factor: 4.429

View more
  1 in total

1.  Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module.

Authors:  Victoria McIlrath; Alice Trye; Ann Aguanno
Journal:  J Vis Exp       Date:  2015-06-18       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.